|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/00 | (2006.01) |
| A61K 31/135 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/439 | (2006.01) | ||
| A61K 31/662 | (2006.01) | ||
| A61K 31/4535 | (2006.01) | ||
| A61P 27/16 | (2006.01) |
| (11) | Number of the document | 1729753 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05736619.7 |
| Date of filing the European patent application | 2005-03-29 | |
| (97) | Date of publication of the European application | 2006-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2009-07-22 |
| (46) | Date of publication of the claims translation | 2009-11-25 |
| (86) | Number | PCT/EP2005/003254 |
| Date | 2005-03-29 |
| (87) | Number | WO 2005/094799 |
| Date | 2005-10-13 |
| (30) | Number | Date | Country code |
| 812298 | 2004-03-29 | US |
| (72) |
GUITTON, Matthieu, FR
PUEL, Jean-Luc, FR
PUJOL, Remy, FR
|
| (73) |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),
101, rue de Tolbiac, 75654 Paris Cédex 13,
FR
Auris Medical AG, Aeschenvorstadt 37, 4051 Basel, CH |
| (74) |
Marija LENKUTIENĖ,
Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | NMDA receptoriaus antagonisto panaudojimas vidinės ausies ekcitotoksiškumo sukelto spengimo gydymui |
| USE OF AN NMDA RECEPTOR ANTAGONIST FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY |
| Payment date | Validity (years) | Amount | |
| 2022-02-18 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-03-29 |